Package Leaflet: Information for the User
Clopidogrel Zentiva 75 mg Film-Coated Tablets
clopidogrel
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Clopidogrel Zentiva contains clopidogrel and belongs to a group of medicines called antiplatelet agents. Platelets are very small cells in the blood that help it to clot. Antiplatelet agents prevent platelet clumping, reducing the risk of blood clots (a process called thrombosis).
Clopidogrel Zentiva is given to adults to prevent blood clots (thrombi) in the blood vessels (arteries) that supply the brain and heart, a process known as atherothrombosis, which can lead to atherothrombotic events (such as stroke, heart attack, or death).
You have been prescribed Clopidogrel Zentiva to help prevent blood clots and reduce the risk of these serious events because you have:
You will have been told that "oral anticoagulants" are more effective than aspirin or the combined use of Clopidogrel Zentiva and aspirin for this condition. Your doctor will have prescribed Clopidogrel Zentiva plus aspirin if you cannot take "oral anticoagulants" and do not have a high risk of major bleeding.
Do not take Clopidogrel Zentiva:
If you think any of these apply to you, or if you are unsure, tell your doctor before taking Clopidogrel Zentiva.
Warnings and precautions
Before starting treatment with Clopidogrel Zentiva, tell your doctor if you:
During treatment with Clopidogrel Zentiva:
Children and adolescents
This medicine should not be given to children because it is not effective.
Taking Clopidogrel Zentiva with other medicines
tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines, including those obtained without a prescription.
Some medicines may affect the use of Clopidogrel Zentiva or vice versa.
You must tell your doctor if you are taking:
If you have had severe chest pain (unstable angina or heart attack), a transient ischemic attack, or a mild ischemic stroke, you may have been prescribed Clopidogrel Zentiva in combination with aspirin, a substance present in many medications used to relieve pain and reduce fever. A dose of aspirin given occasionally (not exceeding 1,000 mg in 24 hours) is generally not a problem, but prolonged use in other circumstances should be discussed with your doctor.
Taking Clopidogrel Zentiva with food and drinks
Clopidogrel Zentiva can be taken with or without food.
Pregnancy and breastfeeding
It is preferable not to take this medicine during pregnancy.
If you are pregnant or think you may be pregnant, you should tell your doctor or pharmacist before taking Clopidogrel Zentiva. If you become pregnant while taking Clopidogrel Zentiva, you should tell your doctor immediately, as it is not recommended to take clopidogrel during pregnancy.
You should not breastfeed while taking this medicine.
If you are breastfeeding or plan to breastfeed, you should tell your doctor before taking this medicine.
Ask your doctor or pharmacist for advice before taking any medicine.
Driving and using machines
Clopidogrel Zentiva is unlikely to affect your ability to drive or use machines.
Clopidogrel Zentiva contains lactose
If your doctor has told you that you have an intolerance to some sugars, you should consult them before taking this medicine.
Clopidogrel Zentiva contains hydrogenated castor oil
This may cause stomach upset and diarrhea.
Take this medicine exactly as your doctor or pharmacist has told you. If you are unsure, ask your doctor or pharmacist.
The recommended dose, even for patients with a condition known as "atrial fibrillation" (an irregular heartbeat), is one 75 mg tablet of Clopidogrel Zentiva per day, taken orally with or without food, and at the same time each day.
If you have had severe chest pain (unstable angina or heart attack), your doctor may prescribe you 300 mg or 600 mg of Clopidogrel Zentiva (1 or 2 tablets of 300 mg or 4 or 8 tablets of 75 mg) to be taken once at the start of treatment. After that, the recommended dose is one 75 mg tablet of Clopidogrel Zentiva per day, as described above.
If you have experienced symptoms of a stroke that disappeared within a short period (also known as a transient ischemic attack) or a mild ischemic stroke, your doctor may prescribe you 300 mg of Clopidogrel Zentiva (1 tablet of 300 mg or 4 tablets of 75 mg) once at the start of treatment. After that, the recommended dose is one 75 mg tablet of Clopidogrel Zentiva per day, as described above, with aspirin for 3 weeks.
After that, your doctor will prescribe either Clopidogrel Zentiva alone or aspirin alone.
You should take Clopidogrel Zentiva for as long as your doctor prescribes it.
If you take more Clopidogrel Zentiva than you should
Contact your doctor or go to the nearest hospital emergency department, as there is a higher risk of bleeding.
If you forget to take Clopidogrel Zentiva
If you forget to take a dose of Clopidogrel Zentiva, but remember before 12 hours have passed since the time you should have taken the medicine, take the tablet immediately and the next one at the usual time.
If you forget for more than 12 hours, simply take the next dose at the usual time. Do not take a double dose to make up for a forgotten tablet.
In the 7, 14, 28, and 84 tablet formats, you can check the last day you took a Clopidogrel Zentiva tablet by looking at the calendar printed on the blister pack.
If you stop taking Clopidogrel Zentiva
Do not stop taking your treatment unless your doctor tells you to.Contact your doctor or pharmacist before stopping treatment with this medicine.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Contact your doctor immediately if you experience:
These may be signs of an allergic reaction.
The most common side effect reported with Clopidogrel Zentiva is bleeding. Bleeding may occur in the stomach or intestine, bruising, hematoma (abnormal bleeding or bruising under the skin), nosebleeds, blood in urine. A small number of cases of bleeding in the blood vessels of the eyes, intracranial bleeding, pulmonary or joint bleeding have also been reported.
If you experience prolonged bleeding while taking Clopidogrel Zentiva
If you cut or injure yourself, bleeding may take a little longer than usual to stop. This is related to the mechanism of action of the medicine, as it prevents the blood from forming clots. For minor cuts or injuries, such as cuts while shaving, this is usually not a problem. However, if you are concerned about your bleeding, consult your doctor immediately (see section 2 "Warnings and precautions").
Other side effects include:
Frequent side effects (may affect up to 1 in 10 people):
Diarrhea, abdominal pain, indigestion, or heartburn.
Uncommon side effects (may affect up to 1 in 100 people):
Headache, stomach ulcer, vomiting, nausea, constipation, excess gas in the stomach or intestine, rash, itching, dizziness, feeling of tingling and numbness.
Rare side effects (may affect up to 1 in 1,000 people):
Dizziness, breast enlargement in men.
Very rare side effects (may affect up to 1 in 10,000 people):
Jaundice, severe abdominal pain with or without back pain; fever, difficulty breathing, sometimes associated with cough; generalized allergic reactions (e.g., feeling of heat throughout the body with sudden general discomfort leading to fainting); swelling of the mouth; blisters on the skin, skin allergy; inflammation of the mouth mucosa (stomatitis); decrease in blood pressure; confusion; hallucinations; joint pain; muscle pain; changes in taste or loss of taste of food.
Side effects with unknown frequency (cannot be estimated from the available data):
Hypersensitivity reactions with chest or abdominal pain, persistent symptoms of low blood sugar.
Your doctor may also observe changes in the results of your blood or urine tests.
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and blister after EXP. The expiry date refers to the last day of the month.
See the storage conditions in the carton.
Store below 30°C when Clopidogrel Zentiva is presented in PVC/PVDC/aluminum blisters. When Clopidogrel Zentiva is presented in any aluminum blister, it does not require special storage conditions.
Do not use this medicine if you notice any visible signs of deterioration.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Clopidogrel Zentiva Composition
The active ingredient is clopidogrel. Each tablet contains 75 mg of clopidogrel (as hydrogen sulfate).
The other components are (see section 2 "Clopidogrel Zentiva contains lactose" and "Clopidogrel Zentiva contains hydrogenated castor oil"):
Product Appearance and Package Contents
Clopidogrel Zentiva 75 mg film-coated tablets (tablets) are round, biconvex, pink, and engraved with the number "75" on one side and the number "1171" on the other. Clopidogrel Zentiva is available in cardboard boxes of:
Only some package sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder:
Zentiva k.s.
U kabelovny 130
102 37 Prague 10
Czech Republic
Manufacturers:
Sanofi Winthrop Industrie
1, Rue de la Vierge, Ambarès & Lagrave, F-33565 Carbon Blanc cedex, France.
or
Delpharm Dijon
6, Boulevard de l’Europe, F - 21800 Quétigny, France
or
S.C. Zentiva S.A.
B-dul Theodor Pallady nr. 50, sector 3,
032266 Bucharest
Romania
For more information about this medicinal product, please contact the local representative of the Marketing Authorization Holder.
Belgium Zentiva, k.s. Tel: +32 280 86 420 PV-Belgium@zentiva.com | Lithuania Zentiva, k.s. Tel: +370 52152025 PV-Lithuania@zentiva.com |
Zentiva, k.s. Tel: + 35924417136 PV-Bulgaria@zentiva.com | Luxembourg Zentiva, k.s. Tel: +352 208 82330 PV-Luxembourg@zentiva.com |
Czech Republic Zentiva, k.s. Tel: +420 267 241 111 PV-Czech-Republic@zentiva.com | Hungary Zentiva Pharma Kft. Tel.: +36 1 299 1058 PV-Hungary@zentiva.com |
Denmark Zentiva Denmark ApS Tlf: +45 787 68 400 PV-Denmark@zentiva.com | Malta Zentiva, k.s. Tel: +356 2778 0890 PV-Malta@zentiva.com |
Germany Zentiva Pharma GmbH Tel: +49 (0) 800 53 53 010 PV-Germany@zentiva.com | Netherlands Zentiva, k.s. Tel: +31 202 253 638 PV-Netherlands@zentiva.com |
Estonia Zentiva, k.s. Tel: +372 52 70308 PV-Estonia@zentiva.com | Norway Zentiva Denmark ApS Tlf: +47 219 66 203 PV-Norway@zentiva.com |
Greece Zentiva, k.s. Tel: +30 211 198 7510 PV-Greece@zentiva.com | Austria Zentiva, k.s. Tel: +43 720 778 877 PV-Austria@zentiva.com |
Spain Zentiva, k.s. Tel: +34 931 815 250 PV-Spain@zentiva.com | Poland Zentiva Polska Sp. z o.o. Tel: + 48 22 375 92 00 PV-Poland@zentiva.com |
France Zentiva France Tel: +33 (0) 800 089 219 PV-France@zentiva.com | Portugal Zentiva Portugal, Lda Tel: +351210601360 PV-Portugal@zentiva.com |
Croatia Zentiva d.o.o. Tel: +385 1 6641 830 PV-Croatia@zentiva.com | Ireland Zentiva, k.s. Tel: +353 818 882 243 PV-Ireland@zentiva.com |
Romania ZENTIVA S.A. Tel: +4 021.304.7597 PV-Romania@zentiva.com | Slovenia Zentiva, k.s. Tel: +386 360 00 408 PV-Slovenia@zentiva.com |
Iceland Zentiva Denmark ApS Phone: +354 539 0650 PV-Iceland@zentiva.com | Slovakia Zentiva, a.s. Tel: +421 2 3918 3010 PV-Slovakia@zentiva.com |
Italy Zentiva Italia S.r.l. Tel: +39-02-38598801 PV-Italy@zentiva.com | Finland Zentiva Denmark ApS Phone/Tel: +358 942 598 648 PV-Finland@zentiva.com |
Cyprus Zentiva, k.s. Tel: +357 240 30 144 PV-Cyprus@zentiva.com | Sweden Zentiva Denmark ApS Tel: +46 840 838 822 PV-Sweden@zentiva.com |
Latvia Zentiva, k.s. Tel: +371 67893939 PV-Latvia@zentiva.com | United Kingdom (Northern Ireland) Zentiva, k.s. Tel: +44 (0) 800 090 2408 PV-United-Kingdom@zentiva.com |
Date of the Last Revision of this Leaflet: <{MM/AAAA}>
Detailed information on this medicinal product is available on the European Medicines Agency website: http://www.ema.europa.eu/